₹ 166.87 Cr
0.15%
NIFTY Healthcare TRI
INF109KC1Q72
1000.0
0.0
500
Nishit Patel, Ashwini Bharucha, Venus Ahuja
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| ICICI Prudential Nifty Healthcare ETF | 10.37 | 23.26 | 13.25 |
| NIFTY Healthcare TRI | 10.96 | 23.1 | 13.28 |
Equity
Debt
Others
The investment objective of the scheme is to provide returns before expenses that closely correspond to the total return of the underlying index subject to tracking errors. However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved.
| Company | Holdings (%) |
|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/- | 19.06 |
| DIVIS LABORATORIES LIMITED EQ NEW RS. 2/- | 8.22 |
| Dr. Reddys Laboratories Ltd | 8.03 |
| APOLLO HOSPITALS ENTERPRISE LIMITED EQ NEW F.V. RS.5/- | 7.82 |
| MAX HEALTHCARE INSTITUTE LIMITED EQ | 7.35 |
| CIPLA LIMITED EQ NEW FV RS.2/- | 7.33 |
| LUPIN LIMITED EQ NEW F.V. RS.2/- | 5.56 |
| FORTIS HEALTHCARE LIMITED. EQ | 4.79 |
| TORRENT PHARMACEUTICALS LIMITED EQ NEW FV RS.5/- | 4.35 |
| LAURUS LABS LIMITED EQ NEW FV RS. 2/- | 4.26 |
| Sector | Holdings (%) |
|---|---|
| Healthcare | 100.0 |
| Scheme Name | 5Y (%) |
|---|---|
| ICICI Pru Nifty Healthcare ETF | 13.25 |